Third-Party Testing vs Manufacturer Testing: What the Difference Actually Means

'Tested' is not a regulated word. A manufacturer running an assay on its own material in its own laboratory can accurately describe that product as tested. So can a brand that sent a sample to an independent accredited laboratory with no commercial stake in the outcome. Both statements are true; they carry very different evidential weight.

The difference is structural rather than a question of honesty. In-house testing means the party with a financial interest in the result is also the party producing it. Third-party testing separates those roles, which is the entire mechanism by which the result becomes independently meaningful.

The relevant benchmark for testing laboratories is ISO/IEC 17025, the international standard for the competence of testing and calibration laboratories. Accreditation to it means an external assessment body has evaluated the laboratory's methods, equipment calibration, personnel competence and quality management system — and re-evaluates periodically.

This is a meaningfully higher bar than a facility simply owning the instrument. Chromatography equipment produces a number regardless of whether the method was properly validated, the column was in specification, or the reference standard was current. Accreditation is what attests to the process behind the number, which is why analytical methods are validated against frameworks such as ICH Q2(R1).

A second distinction matters as much as who tested: what was tested. A specification sheet describes what a product is supposed to contain. A batch-specific Certificate of Analysis reports what one identified production run actually contained, tied to a lot number that appears on the bottle.

Supplement manufacturing is governed by good manufacturing practice requirements — 21 CFR Part 111 in the United States, and FSSAI's nutraceutical regulations in India — which set expectations for identity and quality testing. Those frameworks govern process. They do not require that any resulting document be published for customers to read, which is why publication remains a brand decision rather than a regulatory outcome.

Three questions separate a substantive claim from a decorative one. Does the document name the laboratory that performed the analysis? Does it reference a specific batch or lot number rather than a product category? Does it state the methods used and the results against defined limits, rather than a summary verdict?

Beyond Better publishes a batch-specific Certificate of Analysis covering the Japanese HPLC Standard purity assay, heavy metals, microbial profile and screening against a 545-compound pesticide residue panel — available to read before purchase, not supplied on request afterwards.